Renaissance Technologies
ENTL

Renaissance Technologies’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Renaissance Technologies’s Portfolio ENTL Stock Details ENTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-13,900
Closed -$192K – 3484
2017
Q1 		$192K Sell
13,900
-64,900
-82% -$1.04M ﹤0.01% 3005
2016
Q4 		$1.5M Buy
78,800
+14,800
+23% +$284K ﹤0.01% 2367
2016
Q3 		$1.42M Buy
64,000
+32,600
+104% +$612K ﹤0.01% 2394
2016
Q2 		$574K Buy
31,400
+20,000
+175% +$344K ﹤0.01% 2751
2016
Q1 		$207K Buy
+11,400
New +$184K ﹤0.01% 3075

Other funds holding ENTL

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
DGI
Discovery Group I Chicago, Illinois $262M AUM 29.24% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies's ENTL Position: Q2 2017 in Review

Renaissance Technologies sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q2 2017, closing a stake of 13,900 shares — an estimated $192K sold.

Renaissance Technologies first reported a position in ENTL in Q1 2016 and held it in 5 quarters. The position peaked at $1.5M in Q4 2016. 73 funds tracked by Wall St. Rank hold ENTL as of Q2 2017.

  • Renaissance Technologies reported no remaining Entellus Medical, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Renaissance Technologies sold 13,900 Entellus Medical, Inc. Common Stock shares in Q2 2017, an estimated $192K.
  • Renaissance Technologies first reported a position in Entellus Medical, Inc. Common Stock in Q1 2016 and held it in 5 quarters.
  • Renaissance Technologies's Entellus Medical, Inc. Common Stock position peaked at $1.5M in Q4 2016.
  • 73 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q2 2017.

Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.